Claudin-1 and Claudin-3 as Molecular Regulators of Myelination in Leukoaraiosis Patients

Yan Chen1,2,3,4, Zheng Zheng1,5, Ainong Mei1,2,3,4

  • 1Shengli Clinical Medical College, Fujian Medical University, Fuzhou, 350001, P.R. China.

Abstract

Insights

Claudin-1 and claudin-3 are downregulated in leukoaraiosis, impacting oligodendrocyte viability and myelination. Restoring their expression may offer therapeutic potential for white matter degeneration.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pathology

Background:

  • Leukoaraiosis is characterized by white matter lesions and oligodendrocyte loss, contributing to cognitive decline.
  • Claudin proteins are implicated in leukoaraiosis, but the specific roles of claudin-1 and claudin-3 in oligodendrocytes remain unclear.

Purpose of the Study:

  • To investigate the expression and function of claudin-1 (CLDN1) and claudin-3 (CLDN3) in oligodendrocytes within the context of leukoaraiosis.
  • To determine the impact of claudin-1 and claudin-3 on oligodendrocyte viability, migration, and myelination.

Main Methods:

  • Quantitative polymerase chain reaction (qPCR) to assess gene expression in patients and controls.
  • Oligodendrocyte cell culture (Oli-neu) with silenced or overexpressed claudin-1 and claudin-3.
  • Cellular assays including colony formation, apoptosis, and migration.
  • Western blotting to evaluate myelin protein expression.

Main Results:

  • Claudin-1, claudin-3, and myelinogenesis-related genes (MBP, PLP, OLIG2, SOX10) were downregulated in leukoaraiosis patients.
  • Silencing claudin-1 or claudin-3 reduced oligodendrocyte growth and migration.
  • Overexpression of claudin-1 or claudin-3 decreased oligodendrocyte apoptosis.
  • Claudin-1 and claudin-3 promoted the expression of myelin proteins and transcription factors at the translational level.

Conclusions:

  • Aberrant expression of claudin-1 and claudin-3 significantly influences the pathological progression of leukoaraiosis.
  • These claudins regulate oligodendrocyte viability and myelination, suggesting their potential as therapeutic targets for white matter disorders.